1) Financial Performance Overview
- Centene reported Q3 2026 adjusted diluted EPS of $0.58, exceeding expectations.
- Full-year adjusted EPS guidance raised to > $5.20 from > $4.80.
- Total premium and service revenue for the quarter was $45.1 billion.
- Consolidated HBR improved to 92.7%, with Medicaid at 93.6% and Medicare at 93.8%.

2) Segment Results and Strategy
- Medicaid: Membership declined by 5% YoY to 11.9 million; expected to drop 8-9% by year-end 2026. HBR trajectory is on track for 93.5% for the full year.
- Medicare: Strong performance in both Medicare Advantage and standalone Part D, with breakeven financial results expected in 2026, a year ahead of plan.
- Marketplace: Anticipated full-year pretax margin at the top of the 4.5%-5.0% range, with membership expected around 3.2 million.

3) Operational Challenges and Headwinds
- Increased utilization observed in Florida's Children's Medical Services ahead of program transition, but manageable within overall projections.
- Anticipated membership attrition due to OB3 implementation and work requirements, particularly affecting Medicaid.
- Ongoing challenges with unauthorized enrollment and broker fraud, but reserves accounted for in Q3.

4) Guidance and Future Outlook
- For 2027, Centene expects adjusted EPS growth from a baseline of approximately $4.70, factoring in headwinds from membership attrition and resetting of PDP margins.
- Continued focus on aligning Medicaid rates with acuity, with positive signals from states regarding rate adjustments.
- Plans to enhance product offerings in Marketplace for 2027, focusing on tailored benefit plans and whole health programs.

5) Additional Insights and Missing Information
- The call did not provide specific figures on expected membership changes for 2027 or detailed projections for each segment's growth.
- Further clarity on the impact of state leadership changes post-midterms on Medicaid implementation was not fully addressed.

Bottom line: Centene's Q3 results reflect strong operational performance and improved financial outlook, with strategic focus on Medicaid and Medicare segments. The company is well-positioned to navigate upcoming challenges while aiming for sustainable growth in 2027.